title: Blood-brain barrier genomics, proteomics, and new transporter discovery.
abstract: The blood-brain barrier (BBB) is an impermeable cellular interface that physically separates the blood from the interstices of the brain. The endothelial cells lining the brain blood vessels form the principle barrier, and their unique phenotype is a consequence of dynamic interactions with several perivascular cell types present in the brain parenchyma. In addition, BBB dysfunction has been observed in the large majority of neurological diseases, but the causes of aberrant vascular behavior are generally unknown. Because of its barrier phenotype, drug delivery to the brain has also proven to be a very difficult task. Global genomics and proteomics analyses are currently being used to examine BBB function in healthy and diseased brain to better characterize this dynamic interface. It is becoming increasingly evident that these approaches have the potential to clarify the unique attributes of a healthy BBB, to identify therapeutic targets in diseased brain, and to identify novel conduits for noninvasive delivery of drugs against these targets. This review will discuss the application of genomics and proteomics to blood-brain barrier research and will offer views on the prospects of such approaches.
authors.affiliation: Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA. shusta@engr.wisc.edu
authors.forename: Eric V
authors.initials: EV
authors.lastname: Shusta
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier / Q000502:physiology*; D002352:Carrier Proteins / Q000378:metabolism*; D023281:Genomics; D006801:Humans; D009422:Nervous System Diseases / Q000628:therapy; D040901:Proteomics
chemical_list: D002352:Carrier Proteins
references.citation: Mol Cancer. 2003 Jul 09;2:25
references.pmid: 12904264
references.citation: Physiol Genomics. 2003 Sep 29;15(1):75-83
references.pmid: 12902546
references.citation: J Cereb Blood Flow Metab. 2006 Jul;26(7):959-73
references.pmid: 16306934
references.citation: J Biol Chem. 2003 Oct 31;278(44):43489-95
references.pmid: 12923172
references.citation: Brain Res. 2001 Aug 10;910(1-2):106-15
references.pmid: 11489260
references.citation: Life Sci. 2004 Feb 27;74(15):1899-909
references.pmid: 14761671
references.citation: J Biol Chem. 2002 May 3;277(18):16294-303
references.pmid: 11847224
references.citation: Virology. 1987 Oct;160(2):523-6
references.pmid: 3660593
references.citation: J Clin Invest. 2003 Sep;112(5):736-44
references.pmid: 12952922
references.citation: Electrophoresis. 1997 Mar-Apr;18(3-4):533-7
references.pmid: 9150937
references.citation: Adv Drug Deliv Rev. 2001 Jul 28;49(3):223-35
references.pmid: 11551396
references.citation: Neuroreport. 2003 Oct 6;14(14):1861-5
references.pmid: 14534436
references.citation: J Cereb Blood Flow Metab. 2002 Nov;22(11):1319-26
references.pmid: 12439289
references.citation: In Vitro Cell Dev Biol Anim. 2003 Jul-Aug;39(7):313-20
references.pmid: 14613336
references.citation: Cancer Res. 2003 Oct 15;63(20):6613-25
references.pmid: 14583454
references.citation: J Neurochem. 1991 Dec;57(6):2136-9
references.pmid: 1940920
references.citation: J Biol Chem. 1998 Nov 6;273(45):29635-40
references.pmid: 9792673
references.citation: Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6025-30
references.pmid: 8650213
references.citation: Int J Cancer. 2004 Mar 20;109(2):214-9
references.pmid: 14750172
references.citation: J Virol. 1998 Apr;72(4):2905-16
references.pmid: 9525611
references.citation: FASEB J. 2003 Nov;17(14):2085-7
references.pmid: 12958161
references.citation: J Clin Invest. 1998 Jun 1;101(11):2550-8
references.pmid: 9616226
references.citation: Mol Cell Proteomics. 2002 Jan;1(1):75-82
references.pmid: 12096143
references.citation: Genomics. 2000 Aug 15;68(1):41-56
references.pmid: 10950925
references.citation: Mol Cell Biol. 1999 Mar;19(3):1720-30
references.pmid: 10022859
references.citation: Brain Res Mol Brain Res. 2003 Jul 23;115(2):130-46
references.pmid: 12877984
references.citation: Science. 1995 Oct 20;270(5235):467-70
references.pmid: 7569999
references.citation: Mol Cell Biol. 2000 Mar;20(5):1797-815
references.pmid: 10669755
references.citation: Electrophoresis. 2000 Apr;21(6):1054-70
references.pmid: 10786880
references.citation: BMC Genomics. 2003 Jul 29;4(1):31
references.pmid: 12885301
references.citation: Science. 1995 Oct 20;270(5235):484-7
references.pmid: 7570003
references.citation: J Neurochem. 2004 Apr;89(1):73-89
references.pmid: 15030391
references.citation: Rheumatology (Oxford). 2002 Jun;41(6):605-18
references.pmid: 12048286
references.citation: Cancer Res. 2003 Apr 15;63(8):1865-70
references.pmid: 12702575
references.citation: J Neuropathol Exp Neurol. 2002 Jul;61(7):597-604
references.pmid: 12125738
references.citation: J Cell Biol. 1999 Oct 4;147(1):185-94
references.pmid: 10508865
references.citation: Genome Res. 2000 Nov;10(11):1796-806
references.pmid: 11076864
references.citation: Mol Psychiatry. 2003 Oct;8(10):863-78
references.pmid: 14515137
references.citation: Science. 2001 Feb 16;291(5507):1304-51
references.pmid: 11181995
references.citation: J Neurochem. 1998 May;70(5):1781-92
references.pmid: 9572261
references.citation: Epilepsia. 2001 Dec;42(12):1501-6
references.pmid: 11879359
references.citation: Nature. 2001 Feb 15;409(6822):860-921
references.pmid: 11237011
references.citation: J Cereb Blood Flow Metab. 2001 Jan;21(1):61-8
references.pmid: 11149669
references.citation: Neurosurgery. 2004 Feb;54(2):410-23; discussion 423-5
references.pmid: 14744289
references.citation: J Biol Chem. 1999 Jan 8;274(2):728-34
references.pmid: 9873008
references.citation: J Cereb Blood Flow Metab. 2000 Jul;20(7):1096-102
references.pmid: 10908043
references.citation: J Cell Biol. 2003 May 12;161(3):653-60
references.pmid: 12743111
references.citation: CNS Drugs. 2001;15(8):597-607
references.pmid: 11524032
references.citation: J Cereb Blood Flow Metab. 2002 Mar;22(3):245-52
references.pmid: 11891429